5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 34.34▼ | 34.26▲ | 34.29▲ | 33.73▲ | 34.76▼ |
MA10 | 34.28▲ | 34.36▼ | 34.09▲ | 34.45▼ | 37.21▼ |
MA20 | 34.23▲ | 34.01▲ | 33.66▲ | 34.78▼ | 35.23▼ |
MA50 | 34.35▼ | 33.74▲ | 33.98▲ | 37.68▼ | 36.47▼ |
MA100 | 34.08▲ | 34.13▲ | 34.47▼ | 35.18▼ | 45.55▼ |
MA200 | 33.64▲ | 34.52▼ | 35.52▼ | 35.41▼ | 48.83▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.025▲ | 0.005▲ | 0.116▲ | 0.009▲ | -0.159▼ |
RSI | 53.899▲ | 60.417▲ | 57.382▲ | 44.109▼ | 46.538▼ |
STOCH | 79.286 | 45.080 | 74.953 | 23.383 | 17.123▼ |
WILL %R | -33.898 | -29.845 | -24.062▲ | -56.539 | -85.090▼ |
CCI | 110.312▲ | 28.906 | 69.836 | -29.979 | -83.977 |
Tuesday, September 09, 2025 08:47 PM
Get the latest on Legend Biotech’s CARVYKTI, breakthrough myeloma therapies, market expansion, and pipeline at Morgan Stanley’s 2025 Healthcare Conference.
|
Tuesday, August 26, 2025 12:00 AM
Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.
|
Friday, August 22, 2025 09:00 PM
Legend Biotech Corporation (NASDAQ:LEGN) is one of the most promising future stocks according to Wall Street analysts. On August 12, RBC Capital raised the firm’s price target on Legend Biotech ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/09/25 | 33.91 | 34.74 | 33.69 | 34.34 | 1,122,135 |
15/09/25 | 33.14 | 33.90 | 33.11 | 33.88 | 956,081 |
12/09/25 | 34.09 | 34.455 | 32.695 | 33.11 | 1,724,143 |
11/09/25 | 33.52 | 34.71 | 33.51 | 33.83 | 1,545,916 |
10/09/25 | 33.85 | 34.02 | 33.20 | 33.47 | 2,372,980 |
09/09/25 | 34.75 | 34.84 | 33.42 | 34.25 | 1,317,483 |
08/09/25 | 36.375 | 36.375 | 34.43 | 34.62 | 938,742 |
05/09/25 | 35.40 | 36.48 | 35.29 | 36.08 | 1,463,827 |
04/09/25 | 35.43 | 35.70 | 34.585 | 34.99 | 677,516 |
03/09/25 | 34.20 | 36.17 | 34.1444 | 35.95 | 1,105,498 |
|
|
||||
|
|
||||
|
|